A Novel Controlled PTEN-Knockout Mouse Model for Prostate Cancer Study

被引:7
|
作者
Liu, Sen [1 ]
Zhang, Bing [1 ,2 ]
Rowan, Brian G. [1 ]
Jazwinski, S. Michal [3 ,4 ]
Abdel-Mageed, Asim B. [5 ]
Steele, Chad [6 ]
Wang, Alun R. [7 ]
Sartor, Oliver [5 ,8 ]
Niu, Tianhua [9 ]
Zhang, Qiuyang [1 ,4 ,8 ]
机构
[1] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA
[2] ShenZhen LuoHu Peoples Hosp, Med Lab, Shenzhen, Peoples R China
[3] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA
[4] Tulane Univ, Sch Med, Tulane Ctr Aging, 1430 Tulane Ave, New Orleans, LA 70112 USA
[5] Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA
[6] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA
[7] Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[8] Tulane Univ, Sch Med, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA
[9] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA
基金
美国国家卫生研究院;
关键词
cre-expressing adenovirus; age; prostate cancer; Pten; mouse models; TUMOR-SUPPRESSOR GENE; TRANSGENIC MOUSE; CRE RECOMBINASE; MICE; INACTIVATION; PTEN/MMAC1; EXPRESSION; DELETION; PATHWAY; LEADS;
D O I
10.3389/fmolb.2021.696537
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostate cancer (PCa) is associated with advanced age, but how age contributes to prostate carcinogenesis remains unknown. The prostate-specific Pten conditional knockout mouse model closely imitates human PCa initiation and progression. To better understand how age impacts PCa in an experimental model, we have generated a spatially and temporally controlled Pten-null PCa murine model at different ages (aged vs. non-aged) of adult mice. Here, we present a protocol to inject the Cre-expressing adenovirus with luciferin tag, intraductally, into the prostate anterior lobes of Pten-floxed mice; Pten-loss will be triggered post-Cre expression at different ages. In vivo imaging of luciferin signal following viral infection confirmed successful delivery of the virus and Cre activity. Immunohistochemical staining confirmed prostate epithelial-specific expression of Cre recombinase and the loss of Pten and activation of P-Akt, P-S6, and P-4E-BP1. The Cre-expression, Pten ablation, and activated PI3K/AKT/mTOR pathways were limited to the prostate epithelium. All mice developed prostatic epithelial hyperplasia within 4 weeks after Pten ablation and prostatic intraepithelial neoplasia (PIN) within 8 weeks post-Pten ablation. Some PINs had progressed to invasive adenocarcinoma at 8-16 weeks post-Pten ablation. Aged mice exhibited significantly accelerated PI3K/AKT/mTOR signaling and increased PCa onset and progression compared to young mice. The viral infection success rate is similar to 80%. This model will be beneficial for investigations of cancer-related to aging.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Novel Prognostic Markers in the Serum of Patients With Castration-Resistant Prostate Cancer Derived From Quantitative Analysis of the Pten Conditional Knockout Mouse Proteome
    Kaelin, Martin
    Cima, Igor
    Schiess, Ralph
    Fankhauser, Niklaus
    Powles, Tom
    Wild, Peter
    Templeton, Arnoud
    Cerny, Thomas
    Aebersold, Ruedi
    Krek, Wilhelm
    Gillessen, Silke
    EUROPEAN UROLOGY, 2011, 60 (06) : 1235 - 1243
  • [22] Chemopreventive effects of nanoparticle curcumin in a mouse model of Pten-deficient prostate cancer
    Marco A. De Velasco
    Yan Lu
    Yurie Kura
    Toshiyuki China
    Yasuyuki Inoue
    Akinori Nakayama
    Hiroshi Okada
    Shigeo Horie
    Hirotsugu Uemura
    Hisamitsu Ide
    Human Cell, 2020, 33 : 730 - 736
  • [23] Analysis of noncoding RNA expression in a mouse model of PTEN-deficient prostate cancer
    De Velasco, Marco A.
    Kura, Yurie
    Sakai, Kazuko
    Hatanaka, Yuji
    Fujita, Yoshihiko
    Togashi, Yosuke
    Terashima, Masato
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2016, 76
  • [24] PTEN KNOCKOUT MICE: A NOVEL MODEL OF LUNG FIBROSIS IN SCLERODERMA
    Liu, S.
    Parapuram, S. I. K.
    Sha, W.
    Shi-Wen, X.
    Abraham, D.
    Leask, A.
    RHEUMATOLOGY, 2012, 51 : 36 - 36
  • [25] Prorainbow: A Novel in vivo Prostate Mouse Model to Track the Origin of Prostate Cancer
    Wicks, Elizabeth E.
    Fang, Xiaolan
    Balaji, Kethandapatti C.
    TISSUE ENGINEERING PART A, 2014, 20 : S139 - S140
  • [26] Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma
    Ratnacaram, Chandrahas Kouimar
    Teletin, Marius
    Jiang, Ming
    Meng, Xiangjun
    Chambon, Pierre
    Metzger, Daniel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (07) : 2521 - 2526
  • [27] A NOVEL PTEN FUNCTIONAL PEPTIDE THERAPY FOR PROSTATE CANCER
    Tanaka, Motoyoshi
    Anai, Satoshi
    DeVelasco, Marco
    Saito, Keigo
    Tomioka, Atsushi
    Yoshikawa, Kazuhiro
    Uemura, Hirotsugu
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1183 - 1183
  • [28] MYC activation and PTEN loss synergistically activate proliferation in a mouse model of lethal prostate cancer
    Rubenstein, Michael
    Jones, Tracy
    Hicks, Jessica
    Rege, Apurv
    Zheng, Qizhi
    Gomes-Alexandre, Carolina
    Hubbard, Gretchen
    Yegnasubramanian, Srinivasan
    Bieberich, Charles
    DeMarzo, Angelo
    CANCER RESEARCH, 2024, 84 (06)
  • [29] A novel immunological model for the study of prostate cancer
    Sharma, N
    Luo, J
    Kirschmann, DA
    O'Malley, Y
    Robbins, MEC
    Akporiaye, ET
    Lubaroff, DM
    Heidger, PM
    Hendrix, MJC
    CANCER RESEARCH, 1999, 59 (10) : 2271 - 2276
  • [30] Mouse prostate organoids as a model for prostate cancer
    Foley, Justin A.
    Shah, Kalpit
    Bradbury, Neil A.
    FASEB JOURNAL, 2017, 31